Prelief, Urinozonic Supplement Marketer Warned On Drug Claims, GMPs
This article was originally published in The Rose Sheet
Executive Summary
FDA's Office of Regulatory Affairs warns DSE Healthcare Solutions about violative claims, GMP violations and misbranding problems following an August 2016 inspection at the firm's Edison, N.J., facility.